News

New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients.

X-ray crystallography provides drug template against disease transmitted by small rodents.

Company has announced agreement with GE Healthcare for the manufacture of Protein A ligands.

Company has signed the agreement with ECFP to advance research into the biophysical properties of Lamellasome for bespoke purposes.

Envigo is pleased to announce that Krishnan Kolappaswamy, DVM, DACLAM, Ph.D., Associate Director, Laboratory Animal Medicine-North America, has been appointed to the editorial board of Lab Animal Journal. Dr. Kolappaswamy joins other highly acclaimed scientists and veterinarians on the publication’s editorial board.

Findings represent the first direct evidence that P. gingivalis could be a risk factor for esophageal cancer.

Company has announced a strategic partnership to provide its customers access to broad range of targeted genomics and metabolomics services.

Diversigen to offer both metagenomic/microbiome analysis and host genetics for customers interested in a broader understanding of health and disease in the whole human.

Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.

BioAgilytix has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity.